168 related articles for article (PubMed ID: 7931358)
1. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease.
Hartley A; Stone JM; Heron C; Cooper JM; Schapira AH
J Neurochem; 1994 Nov; 63(5):1987-90. PubMed ID: 7931358
[TBL] [Abstract][Full Text] [Related]
2. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
[TBL] [Abstract][Full Text] [Related]
3. Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures.
McNaught KS; Jenner P
J Neurochem; 1999 Dec; 73(6):2469-76. PubMed ID: 10582607
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.
Höglinger GU; Carrard G; Michel PP; Medja F; Lombès A; Ruberg M; Friguet B; Hirsch EC
J Neurochem; 2003 Sep; 86(5):1297-307. PubMed ID: 12911637
[TBL] [Abstract][Full Text] [Related]
5. Quantitative study of mitochondrial complex I in platelets of parkinsonian patients.
Blandini F; Nappi G; Greenamyre JT
Mov Disord; 1998 Jan; 13(1):11-5. PubMed ID: 9452319
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins.
Seaton TA; Cooper JM; Schapira AH
Brain Res; 1998 Oct; 809(1):12-7. PubMed ID: 9795106
[TBL] [Abstract][Full Text] [Related]
7. Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium.
King TD; Bijur GN; Jope RS
Brain Res; 2001 Nov; 919(1):106-14. PubMed ID: 11689167
[TBL] [Abstract][Full Text] [Related]
8. Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease.
Tai KK; Truong DD
J Neurosci Res; 2002 Aug; 69(4):559-66. PubMed ID: 12210849
[TBL] [Abstract][Full Text] [Related]
9. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors.
Seaton TA; Cooper JM; Schapira AH
Brain Res; 1997 Nov; 777(1-2):110-8. PubMed ID: 9449419
[TBL] [Abstract][Full Text] [Related]
10. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
[TBL] [Abstract][Full Text] [Related]
11. Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model.
Choi WS; Palmiter RD; Xia Z
J Cell Biol; 2011 Mar; 192(5):873-82. PubMed ID: 21383081
[TBL] [Abstract][Full Text] [Related]
12. DJ-1 protects dopaminergic neurons against rotenone-induced apoptosis by enhancing ERK-dependent mitophagy.
Gao H; Yang W; Qi Z; Lu L; Duan C; Zhao C; Yang H
J Mol Biol; 2012 Oct; 423(2):232-48. PubMed ID: 22898350
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholinesterase deficiency decreases apoptosis in dopaminergic neurons in the neurotoxin model of Parkinson's disease.
Zhang X; Lu L; Liu S; Ye W; Wu J; Zhang X
Int J Biochem Cell Biol; 2013 Feb; 45(2):265-72. PubMed ID: 23201480
[TBL] [Abstract][Full Text] [Related]
14. p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease.
Wu F; Wang Z; Gu JH; Ge JB; Liang ZQ; Qin ZH
Neurochem Int; 2013 Sep; 63(3):133-40. PubMed ID: 23714208
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.
Casarejos MJ; Menéndez J; Solano RM; Rodríguez-Navarro JA; García de Yébenes J; Mena MA
J Neurochem; 2006 May; 97(4):934-46. PubMed ID: 16573651
[TBL] [Abstract][Full Text] [Related]
16. Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
Betarbet R; Sherer TB; MacKenzie G; Garcia-Osuna M; Panov AV; Greenamyre JT
Nat Neurosci; 2000 Dec; 3(12):1301-6. PubMed ID: 11100151
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone.
Krueger MJ; Singer TP; Casida JE; Ramsay RR
Biochem Biophys Res Commun; 1990 May; 169(1):123-8. PubMed ID: 2350337
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons.
Alvira D; Tajes M; Verdaguer E; de Arriba SG; Allgaier C; Matute C; Trullas R; Jiménez A; Pallàs M; Camins A
Neuroscience; 2007 Apr; 146(1):350-65. PubMed ID: 17343987
[TBL] [Abstract][Full Text] [Related]
19. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease.
Li H; Dryhurst G
J Neurochem; 1997 Oct; 69(4):1530-41. PubMed ID: 9326282
[TBL] [Abstract][Full Text] [Related]
20. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism.
Storch A; Kaftan A; Burkhardt K; Schwarz J
Brain Res; 2000 Feb; 855(1):67-75. PubMed ID: 10650131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
